INVOLVEMENT OF THE FAS FAS LIGAND PATHWAY IN ACTIVATION-INDUCED CELL-DEATH OF MYCOBACTERIA-REACTIVE HUMAN GAMMA-DELTA T-CELLS - A MECHANISMFOR THE LOSS OF GAMMA-DELTA T-CELLS IN PATIENTS WITH PULMONARY TUBERCULOSIS/
Bq. Li et al., INVOLVEMENT OF THE FAS FAS LIGAND PATHWAY IN ACTIVATION-INDUCED CELL-DEATH OF MYCOBACTERIA-REACTIVE HUMAN GAMMA-DELTA T-CELLS - A MECHANISMFOR THE LOSS OF GAMMA-DELTA T-CELLS IN PATIENTS WITH PULMONARY TUBERCULOSIS/, The Journal of immunology (1950), 161(3), 1998, pp. 1558-1567
Although the identity of T cells involved in the protection against My
cobacterium tuberculosis (Mtb) in humans remain unknown, patients with
pulmonary tuberculosis (TB) hare reduced numbers of Mtb-reactive, V g
amma 9(+)/V delta 2(+) T cells in their blood and lungs. sere ne have
determined whether this gamma delta T loss is a consequence of Mtb Ag-
mediated activation-induced cell death (AICD). Using a DNA polymerase-
mediated dUTP nick translation labeling assay, 5% or less of freshly i
solated CD4(+) alpha beta or gamma delta T cells from normal healthy i
ndividuals and TB patients were apoptotic. However, during culture Mtb
Ags, induced apoptosis in a large proportion of V gamma 9(+)/V delta
2(+) peripheral blood T cells from healthy subjects (30-45%) and TB pa
tients (55-68%); this was increased further in the presence of IL-2, B
y contrast, anti-CD3 did not induce any significant level of apoptosis
In gamma delta T cells from healthy subjects or TB patients. Mtb Ag s
timulation rapidly induced Fas and Fas ligand (FasL) expression by gam
ma delta T cells, and in the presence of metalloproteinase-inhibitors
>70% of gamma delta T cells were FasL(+). Blockade of Fas-FasL interac
tions reduced the level of Mtb-mediated gamma delta T cell apoptosis b
y 75 to 80%. Collectively, these findings demonstrate that Mtb-reactiv
e gamma delta T cells are more susceptible to AICD and that the Fas-Fa
sL pathways of apoptosis is involved. AICD of gamma delta T cells, the
refore, provides an explanation for the loss of Mtb-reactive T cells d
uring mycobacterial infection.